This document discusses endometrial hyperplasia, a condition characterized by an excessive proliferation of endometrial glands. It can progress to endometrial carcinoma if left untreated, making atypical hyperplasia a premalignant lesion. Risk factors include unopposed estrogen exposure from sources like estrogen therapy, obesity, or hormone-secreting tumors. The document classifies hyperplasia into simple, complex, and atypical subtypes based on histological features and lists their risks of progression to cancer, with atypical forms having the highest risk.